Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP934763.RAzOzerUrpgvsElkEXTM1E0dBEk5-Ni4R2D27D3vM2Ey8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP934763.RAzOzerUrpgvsElkEXTM1E0dBEk5-Ni4R2D27D3vM2Ey8130_assertion type Assertion NP934763.RAzOzerUrpgvsElkEXTM1E0dBEk5-Ni4R2D27D3vM2Ey8130_head.
- NP934763.RAzOzerUrpgvsElkEXTM1E0dBEk5-Ni4R2D27D3vM2Ey8130_assertion description "[Moreover, maintenance of a normal endogenous ACE2 compensatory activity in the pancreas appears critical to avoid ?-cell dysfunction, supporting a therapeutic potential for ACE2 in controlling diabetes resulting from an overactive RAS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP934763.RAzOzerUrpgvsElkEXTM1E0dBEk5-Ni4R2D27D3vM2Ey8130_provenance.
- NP934763.RAzOzerUrpgvsElkEXTM1E0dBEk5-Ni4R2D27D3vM2Ey8130_assertion evidence source_evidence_literature NP934763.RAzOzerUrpgvsElkEXTM1E0dBEk5-Ni4R2D27D3vM2Ey8130_provenance.
- NP934763.RAzOzerUrpgvsElkEXTM1E0dBEk5-Ni4R2D27D3vM2Ey8130_assertion SIO_000772 23462816 NP934763.RAzOzerUrpgvsElkEXTM1E0dBEk5-Ni4R2D27D3vM2Ey8130_provenance.
- NP934763.RAzOzerUrpgvsElkEXTM1E0dBEk5-Ni4R2D27D3vM2Ey8130_assertion wasDerivedFrom befree-20150227 NP934763.RAzOzerUrpgvsElkEXTM1E0dBEk5-Ni4R2D27D3vM2Ey8130_provenance.
- NP934763.RAzOzerUrpgvsElkEXTM1E0dBEk5-Ni4R2D27D3vM2Ey8130_assertion wasGeneratedBy ECO_0000203 NP934763.RAzOzerUrpgvsElkEXTM1E0dBEk5-Ni4R2D27D3vM2Ey8130_provenance.